ESHALLGO INC (EHGO)

KYG3121H1039 - Common Stock

3.6332  +0.07 (+2.06%)

Premarket: 4 +0.37 (+10.1%)

Fundamental Rating

3

EHGO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Commercial Services & Supplies industry. EHGO has a great financial health rating, but its profitability evaluates not so good. EHGO is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

EHGO had positive earnings in the past year.
In the past year EHGO had a positive cash flow from operations.

1.2 Ratios

EHGO has a Return On Assets (2.31%) which is comparable to the rest of the industry.
With a Return On Equity value of 4.42%, EHGO perfoms like the industry average, outperforming 53.09% of the companies in the same industry.
EHGO has a Return On Invested Capital (6.10%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EHGO is above the industry average of 10.09%.
The last Return On Invested Capital (6.10%) for EHGO is well below the 3 year average (13.47%), which needs to be investigated, but indicates that EHGO had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.31%
ROE 4.42%
ROIC 6.1%
ROA(3y)8.37%
ROA(5y)N/A
ROE(3y)15.81%
ROE(5y)N/A
ROIC(3y)13.47%
ROIC(5y)N/A

1.3 Margins

EHGO's Profit Margin of 2.59% is in line compared to the rest of the industry. EHGO outperforms 56.79% of its industry peers.
EHGO has a Operating Margin (7.15%) which is comparable to the rest of the industry.
The Gross Margin of EHGO (25.50%) is worse than 62.96% of its industry peers.
Industry RankSector Rank
OM 7.15%
PM (TTM) 2.59%
GM 25.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EHGO is creating some value.
Compared to 1 year ago, EHGO has about the same amount of shares outstanding.
Compared to 1 year ago, EHGO has a worse debt to assets ratio.

2.2 Solvency

EHGO has an Altman-Z score of 7.30. This indicates that EHGO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.30, EHGO belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
EHGO has a debt to FCF ratio of 0.34. This is a very positive value and a sign of high solvency as it would only need 0.34 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.34, EHGO belongs to the top of the industry, outperforming 91.36% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that EHGO is not too dependend on debt financing.
EHGO has a better Debt to Equity ratio (0.01) than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Altman-Z 7.3
ROIC/WACC0.81
WACC7.54%

2.3 Liquidity

EHGO has a Current Ratio of 4.85. This indicates that EHGO is financially healthy and has no problem in meeting its short term obligations.
EHGO's Current ratio of 4.85 is amongst the best of the industry. EHGO outperforms 90.12% of its industry peers.
A Quick Ratio of 4.24 indicates that EHGO has no problem at all paying its short term obligations.
EHGO has a better Quick ratio (4.24) than 90.12% of its industry peers.
Industry RankSector Rank
Current Ratio 4.85
Quick Ratio 4.24

0

3. Growth

3.1 Past

EHGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.87%.
Looking at the last year, EHGO shows a very negative growth in Revenue. The Revenue has decreased by -22.83% in the last year.
EPS 1Y (TTM)-73.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.87%
Revenue 1Y (TTM)-22.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 181.66, which means the current valuation is very expensive for EHGO.
Compared to the rest of the industry, the Price/Earnings ratio of EHGO indicates a slightly more expensive valuation: EHGO is more expensive than 66.67% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of EHGO to the average of the S&P500 Index (27.40), we can say EHGO is valued expensively.
Industry RankSector Rank
PE 181.66
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EHGO is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EHGO indicates a slightly more expensive valuation: EHGO is more expensive than 60.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 183.62
EV/EBITDA 42.63

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EHGO!.
Industry RankSector Rank
Dividend Yield N/A

ESHALLGO INC

NASDAQ:EHGO (1/6/2025, 8:00:01 PM)

Premarket: 4 +0.37 (+10.1%)

3.6332

+0.07 (+2.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.04%
Ins Owner ChangeN/A
Market Cap78.95M
AnalystsN/A
Price TargetN/A
Short Float %0.37%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 181.66
Fwd PE N/A
P/S 4.28
P/FCF 183.62
P/OCF 100.71
P/B 7.31
P/tB 7.31
EV/EBITDA 42.63
EPS(TTM)0.02
EY0.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.54%
OCF(TTM)0.04
OCFY0.99%
SpS0.85
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.31%
ROE 4.42%
ROCE 7.78%
ROIC 6.1%
ROICexc 9.2%
ROICexgc 9.2%
OM 7.15%
PM (TTM) 2.59%
GM 25.5%
FCFM 2.33%
ROA(3y)8.37%
ROA(5y)N/A
ROE(3y)15.81%
ROE(5y)N/A
ROIC(3y)13.47%
ROIC(5y)N/A
ROICexc(3y)21.34%
ROICexc(5y)N/A
ROICexgc(3y)21.34%
ROICexgc(5y)N/A
ROCE(3y)17.07%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Debt/EBITDA 0.09
Cap/Depr 93.16%
Cap/Sales 1.92%
Interest Coverage 250
Cash Conversion 46.18%
Profit Quality 90.01%
Current Ratio 4.85
Quick Ratio 4.24
Altman-Z 7.3
F-Score4
WACC7.54%
ROIC/WACC0.81
Cap/Depr(3y)268.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.65%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y139.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y591.75%
OCF growth 3YN/A
OCF growth 5YN/A